FORBES recently announced that the net worth of Elizabeth Holmes, founder and CEO of Theranos, a 13-year-old blood testing company, has fallen from $4.5 billion to $0.
FORBES estimated Theranos was worth about $800 million and concluded that since she likely owns common shares and investors own preferred, Holmes’s stake in the company would be worthless after the investors got their share should the company be sold.